SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-16-010039
Filing Date
2016-01-11
Accepted
2016-01-11 16:38:40
Documents
2
Period of Report
2016-01-05
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO CURRENT REPORT f8k010516a1_tianyinpharma.htm 8-K/A 31073
2 PRESS RELEASE DATED JANUARY 11, 2016 f8k010516a1ex99i_tianyin.htm EX-99.1 11540
  Complete submission text file 0001213900-16-010039.txt   43998
Mailing Address 23RD FLOOR, UNIONSUN YANGKUO PLAZA NO.2, BLOCK 3, RENMIN ROAD SOUTH CHENGDU, P.R. F4 610041
Business Address 23RD FLOOR, UNIONSUN YANGKUO PLAZA NO.2, BLOCK 3, RENMIN ROAD SOUTH CHENGDU, P.R. F4 610041 0086-028-86154737
TIANYIN PHARMACEUTICAL CO., INC. (Filer) CIK: 0001362718 (see all company filings)

IRS No.: 204857782 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-34189 | Film No.: 161336776
SIC: 2834 Pharmaceutical Preparations